The hematologist from UC Health discussed the role of allogeneic stem cell transplant at first remission based on risk stratification.
Dan Pollyea, MD, MS
Advertisement
Hematologist from UC Health
Articles by Dan Pollyea, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
2
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
3
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
4
Quarter Century Update: Platform Approaches and Industry Investment
5
